Q3

Thyrocare Technologies Ltd

THYROCAREFY2503 Feb 2025

Revenue-6.5%

Net Profit-28.2%

OPM3.87%

P&L

Quarterly Consolidated

Revenue

-6.5%165.92

Expenditure

-0.7%141.84

Net Profit

-28.2%18.96

NPM 11.25%-24.2%EPS ₹3.58-28.3%

vs Q2 FY25

Informational and educational content only. Not investment advice.